Outpace Bio raises $30m led by Artis Ventures, Lyell
The Seattle-based company raises funding from in an oversubscribed round led by Artis Ventures and Lyell Immunopharma.
The Seattle-based company raises funding from in an oversubscribed round led by Artis Ventures and Lyell Immunopharma.
Copyright PEI Media
Not for publication, email or dissemination